Moreover, to evaluate the independent impact of spondin-2 overexpression on RFS and OS, a multivariate Cox regression model adjusted for tumor size, tumor site, depth of invasion, lymph node metastasis and spondin-2 expression was performed. This evidence concerns the gene SPON2 and metastatic malignant neoplasm in the lymph nodes.